Significant step forward proposed for bowel cancer

PHARMAC

5 August 2024 - PHARMAC is looking to fund a medicine for bowel cancer that would help people live longer.

Public consultation has opened on PHARMAC’s proposal to fund cetuximab (Erbitux) for a type of bowel cancer where the cancer is located on the left side of the bowel and has spread to other parts of the body.

Read PHARMAC press release

Michael Wonder

Posted by:

Michael Wonder